Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Tenderness, Vaccination site erythema, Vaccination site inflammation, Vaccination site warmth
Clinical narrative: Developed a red warm raised inflammation at injection site that grew in size from a quarter within 1hour of injection to size of my palm by 2 days.; Section stayed red warm and raised for 3-4 weeks; Section stayed red warm and raised for 3-4 weeks; Soreness and tender to touch.; Soreness and tender to touch.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 18Nov2021 15:30 (Lot number: 30135BA) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Insulin resistance" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: TIROSINT; METFORMIN; CYTOMEL. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False,, Prev dose lot number: EL3248,, Prev dose lot unknown=False,, Prev dose administration date=08Jan2021 , Prev dose number=2, Prev dose vaccine location=Right arm), administration date: 08Jan2021, when the patient was 46 years old, for Covid-19 immunization, reaction(s): "On dose 1 and 2 of Pfizer Covid vaccine, saw a much smaller red warm spot about quarter to half dollar in size", "On dose 1 and 2 of Pfizer Covid vaccine, saw a much smaller red warm spot about quarter to half dollar in size", "1st dose:22Dec2020;2nd dose:08Jan2021", "1st dose:22Dec2020;2nd dose:08Jan2021"; Bnt162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, Prev dose brand unknown=False,, Prev dose lot number: EK5730,, Prev dose lot unknown=False,, Prev dose administration date=22Dec2020 , Prev dose number=1, Prev dose vaccine location=Right arm), administration date: 22Dec2020, when the patient was 46 years old, for Covid-19 immunization, reaction(s): "On dose 1 and 2 of Pfizer Covid vaccine, saw a much smaller red warm spot about quarter to half dollar in size", "On dose 1 and 2 of Pfizer Covid vaccine, saw a much smaller red warm spot about quarter to half dollar in size". The following information was reported: VACCINATION SITE INFLAMMATION (non-serious) with onset 18Nov2021 16:30, outcome "recovered with sequelae", described as "Developed a red warm raised inflammation at injection site that grew in size from a quarter within 1hour of injection to size of my palm by 2 days."; VACCINATION SITE WARMTH (non-serious), VACCINATION SITE ERYTHEMA (non-serious) all with onset 18Nov2021 16:30, outcome "recovered with sequelae" and all described as "Section stayed red warm and raised for 3-4 weeks"; PAIN (non-serious), TENDERNESS (non-serious) all with onset 18Nov2021 16:30, outcome "recovered with sequelae" and all described as "Soreness and tender to touch.". Therapeutic measures were not taken as a result of vaccination site inflammation, vaccination site warmth, vaccination site erythema, pain, tenderness.  Follow-up (23Feb2022): Follow-up attempts are completed. No further information is expected.